The Advanced Scientific Research of the RELATECH S.P.A. at the service of innovative systems for the early identification of biomarkers
Relatech S.p.A., Digital Enabler Solution Knowledge (D.E.S.K.) Company and Innovative SME listed on the AIM Italia market (Ticker: RLT), announces that as part of a research project involving Ithea s.r.l. - company founded as a spinf-off of the University of Calabria with the participation of professors also from the School of Medicine and Surgery of the University of Catanzaro and today part of the Relatech S.p.A. Group - The preliminary but very promising results of a work on possible applications of Artificial Intelligence and machine learning applicable to the extraction of biomarkers from biological samples were presented.
At the first edition of the workshop on artificial intelligence applications for personalized medicine and wellbeing (Artificial intelligence for Health, Personalized Medicine and wellbeing) held as part of the conference - ECAI 2020, the first results of one of the R&D activities were presented of the Relatech Group carried out in the field of data analysis and machine learning technologies applied to biomedicine. Thanks to the collaboration with a group of University Professors and qualified Researchers of the University of Catanzaro as part of a research and development project, Relatech has contributed to the implementation of an academic work on the possibility of extracting biomarkers from biological data extracted from samples clinical and spectrometric data.